Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Haemonetics Corporation (HAE)

76.34   0.26 (0.34%) 03-24 12:52
Open: 75.35 Pre. Close: 76.08
High: 76.56 Low: 75.8
Volume: 140,468 Market Cap: 3,851(M)

Technical analysis

as of: 2023-03-24 12:01:30 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 92.43     One year: 96.04
Support: Support1: 74.12    Support2: 61.67
Resistance: Resistance1: 79.13    Resistance2: 82.23
Pivot: 77.15
Moving Average: MA(5): 77.55     MA(20): 77.35
MA(100): 81.13     MA(250): 72.8
MACD: MACD(12,26): -1.1     Signal(9): -1.2
Stochastic oscillator: %K(14,3): 37.8     %D(3): 56.7
RSI: RSI(14): 42.9
52-week: High: 91.38  Low: 48.66
Average Vol(K): 3-Month: 408 (K)  10-Days: 322 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ HAE ] has closed above bottom band by 31.2%. Bollinger Bands are 45.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 78 - 78.53 78.53 - 78.96
Low: 74.86 - 75.37 75.37 - 75.79
Close: 75.34 - 76.16 76.16 - 76.84

Company Description

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Headline News

Fri, 24 Mar 2023
Globus Medical (GMED) to Gain From NUVA Deal Amid Rising Costs - Nasdaq

Fri, 24 Mar 2023
Smith & Nephew's (SNN) CIT Technology Favored by New Study - Nasdaq

Thu, 23 Mar 2023
Syneos Health (SYNH) Partners With KX for Data-Driven Insights - Nasdaq

Wed, 22 Mar 2023
Henry Schein (HSIC) Bolsters Dental Practices With AI Tools - Nasdaq

Tue, 21 Mar 2023
Quest Diagnostics (DGX) Acquires Northern Light Laboratory - Nasdaq

Mon, 20 Mar 2023
Cardiovascular Systems (CSII) Ails From Soft Volume, Macro Woes - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 50 (M)
Shares Float 50 (M)
% Held by Insiders 0.6 (%)
% Held by Institutions 101.3 (%)
Shares Short 1,260 (K)
Shares Short P.Month 1,280 (K)

Stock Financials

EPS 1.84
EPS Est Next Qtl 0.44
EPS Est This Year 1.61
EPS Est Next Year 1.83
Book Value (p.s.) 15.38
Profit Margin (%) 8.4
Operating Margin (%) 14.6
Return on Assets (ttm) 5.5
Return on Equity (ttm) 12.7
Qtrly Rev. Growth 17.5
Gross Profit (p.s.) 10.52
Sales Per Share 22.39
EBITDA (p.s.) 5.08
Qtrly Earnings Growth 42.2
Operating Cash Flow 262 (M)
Levered Free Cash Flow 105 (M)

Stock Valuations

PE Ratio 41.39
PEG Ratio 2.6
Price to Book value 4.95
Price to Sales 3.4
Price to Cash Flow 14.69

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.